J.P.W. Vermeiden
VU University Amsterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J.P.W. Vermeiden.
The Lancet | 2000
Angelique J Goverde; Joseph McDonnell; J.P.W. Vermeiden; Roel Schats; Frans Rutten; Joop Schoemaker
BACKGROUND Couples affected by idiopathic subfertility or male subfertility have an estimated spontaneous conception rate of about 2% per cycle. Although various infertility treatments are available, counselling of a couple in their choice of treatment is difficult because of the lack of consistent data from good-quality comparative studies. We compared the results of treatment with intrauterine insemination (IUI) with those of in-vitro fertilisation (IVF), and did a cost-effectiveness analysis. METHODS In a prospective, randomised, parallel trial, 258 couples with idiopathic subfertility or male subfertility were treated for a maximum of six cycles of either IUI in the spontaneous cycle (IUI alone), IUI after mild ovarian hyperstimulation, or IVF. The primary endpoint was a pregnancy resulting in at least one livebirth after treatment. Cost-effectiveness based on real costs was studied by Markov chain analysis. FINDINGS 86 couples were assigned IUI alone, 85 IUI plus ovarian hyperstimulation, and 87 IVF. Ten couples dropped out before treatment began. Although the pregnancy rate per cycle was higher in the IVF group than in the IUI groups (12.2% vs 7.4% and 8.7%, respectively; p=0.09), the cumulative pregnancy rate for IVF was not significantly better than that for IUI. Couples in the IVF group were more likely than those in the IUI groups to give up treatment before their maximum of six attempts (37 [42%] drop-outs vs 13 [15%] and 14 [16%], respectively; p<0.01). The womans age was the only factor that influenced a couples chance of success. IUI was a more cost-effective treatment than IVF (costs per pregnancy resulting in at least one livebirth 8423-10661 Dutch guilders [US
Chemico-Biological Interactions | 2000
Floris W.P.C. van Overveld; Guido R.M.M. Haenen; Johann Rhemrev; J.P.W. Vermeiden; Aalt Bast
4511-5710] for IUI vs 27409 Dutch guilders [US
Fertility and Sterility | 2001
Johann Rhemrev; Jan Willem Lens; Joseph McDonnell; Joop Schoemaker; J.P.W. Vermeiden
14679] for IVF). INTERPRETATION Couples with idiopathic or male subfertility should be counselled that IUI offers the same likelihood of successful pregnancy as IVF, and is a more cost-effective approach. IUI in the spontaneous cycle carries fewer health risks than does IUI after mild hormonal stimulation and is therefore the first-choice treatment.
Fertility and Sterility | 1989
J.P.W. Vermeiden; Rob E. Bernardus; Catharina S. ten Brug; Catharina H. Statema-Lohmeijer; Anke M. Willemsen-Brugma; Joop Schoemaker
A novel post-addition method, based on the trapping of ABTS-radicals, is applied for studying the total antioxidant capacity of seminal plasma. A remarkable profile is observed, in which seminal plasma quenches radicals in a continuous, relatively slow fashion. Five putative antioxidants present in seminal plasma were studied using the same assay. Some of the compounds such as ascorbic acid, alpha-tocopherol and uric acid exert immediate, fast radical trapping, whereas hypotaurine and tyrosine give rise to the same slow radical trapping curve as seminal plasma. Due to this slow, continuous radical trapping, quantification of the total antioxidant capacity (expressed as trolox equivalent antioxidant capacity, TEAC) strongly depends on the chosen time point after onset of radical trapping. When determined during the slow antioxidant trapping phase, tyrosine has a powerful antioxidant capacity, which in combination with its relatively high plasma concentration makes it an important contributor to the total antioxidant capacity of seminal plasma.
Human Reproduction | 2007
Marianne E. Doornbos; Saskia M. Maas; Joseph McDonnell; J.P.W. Vermeiden; Raoul C. M. Hennekam
OBJECTIVE To predict the chance of total fertilization failure (TFF) before the day of ovum pickup with known semen and female variables. DESIGN A statistical model was constructed to predict TFF by retrospective analysis (2,366 couples) and subsequently tested on a new IVF population (917 couples). SETTING Academic tertiary referral center. PATIENT(S) Three thousand three hundred eighty-three couples who underwent an IVF-ET treatment. INTERVENTION(S) None. MAIN OUTCOME MEASURE(S) The ability to predict the probability of TFF in IVF. RESULT(S) Two variables-postwash total progressively motile sperm cell count (postwash TPMC) and number of follicles-were found to be significant. Taking a probability of 25% as an acceptable risk of TFF, we calculated that a postwash TPMC of <1.1 x 10(6) cells results in a risk of TFF of >25%. Low responders (<4 follicles) needed a postwash TPMC of >2.2 x 10(6) cells to reduce the risk of TFF to <25%. High responders (>15 follicles) needed only 0.35 x 10(6) postwash progressively motile spermatozoa. CONCLUSION(S) When postwash TPMC and number of follicles are known and an unacceptable TFF outcome is expected, one can propose an ICSI procedure a few days before the day of ovum pickup.
Human Reproduction | 1995
T.J. Roseboom; J.P.W. Vermeiden; E. Schoute; J.W. Lens; Roel Schats
In 115 patients (group I) in which normal liquefaction of semen occurred, the fertilization rate of the yielded oocytes was 71.2% after standard in vitro fertilization procedure, and the viable pregnancy rate per patient per cycle was 13.0%. In a comparable group of 26 patients (group II), in which semen liquefaction did not occur spontaneously, alpha-amylase was added in order to liquefy the semen. In this group, the fertilization rate was 86.7% of the yielded oocytes, and the viable pregnancy rate per patient per cycle was 26.9% (P less than 0.05). It is concluded that alpha-amylase can be of use to liquefy nonliquefying semen, and that the resultant spermatozoa have a positive effect on pregnancy results.
Human Reproduction | 2000
R.M.J. Janssens; C.B. Lambalk; J.P.W. Vermeiden; Roel Schats; J.M. Bernards; Lyset T. M. Rekers-Mombarg; Joop Schoemaker
Journal of Andrology | 2005
Diarmaid H. Douglas‐Hamilton; Nancy G. Smith; Christopher E. Kuster; J.P.W. Vermeiden; G.C. Althouse
Human Reproduction | 2000
R.M.J. Janssens; C.B. Lambalk; J.P.W. Vermeiden; Roel Schats; Joop Schoemaker
Journal of Andrology | 2005
Diarmaid H. Douglas‐Hamilton; Nancy G. Smith; Christopher E. Kuster; J.P.W. Vermeiden; G.C. Althouse